Cempra Inc (CEMP) Stock: Time Runs Out, FDA Rejects NDA

Cempra Inc (NASDAQ: CEMP) Well, tick, tock went the clock for CEMP as CNA Finance covered yesterday, but unfortunately for CEMP, time appears to have run out on its solithromycin NDA. On Thursday, CEMP said that they have received a complete response letter from the FDA regarding its NDA for solithromycin, a treatment for community-acquired … Read more

Cempra (CEMP) Stock: Tick, Tock, Goes The FDA Clock

Cempra Inc (NASDAQ: CEMP) Cempra Inc. is essentially all-in at this point in time, with two vitally important PFUDA reviews pending this week for solithromycin, its drug intended to treat community-acquired bacterial pneumonia. We received a trading tool, news alert from Trade Ideas that brought our focus to CEMP. The FDA is set to render … Read more

BioTech Stocks Are Starting To Recover | OREX | MNKD | ICPT

US stocks have had an incredibly rough time in the market this week. Mid last week, the Federal Reserve made a statement that they would not be aggressive in increasing interest rates. While the lack of aggression made investors happy short term, it seems as though reality set in early this week as the Dow … Read more